Amgen
Robert Bernstein is an experienced legal professional specializing in intellectual property and patent law. Currently serving as Senior Counsel at Amgen since October 2022, Robert previously held roles such as Senior Director of Patents and Research at ChemoCentryx until its acquisition by Amgen and Senior Director of Intellectual Property at Plexxikon Inc. from February 2015 to April 2022. Earlier in the career, Robert worked as Senior Patent Attorney at Exelixis from July 2006 to January 2011. Robert holds a Master of Science in Chemistry from Stanford University and a Juris Doctor degree with an emphasis on Intellectual Property from Franklin Pierce Law Center.
This person is not in any offices
Amgen
275 followers
Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology.